Royalty Pharma plc (RPRX) has 9 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 4 sales totalling $15.3M. Most recent filing: Aug. 19, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 19, 2026 filed Aug. 18, 2026 | Hite Christopher EVP & Chairman, Partnering | −$5,997,250 | 116,800 | −83% | Yes | |
|
|
||||||
| Aug. 17, 2026 filed Aug. 13, 2026 | Coyne Terrance P. EVP & CFO | −$645,551 | 11,002 | −100% | Yes | |
|
|
||||||
| Aug. 7, 2026 filed Aug. 5, 2026 | Legorreta Pablo G. CEO, Chairman of the Board | $0 | 95,216 | +11% | No | |
|
|
||||||
| Aug. 7, 2026 filed Aug. 5, 2026 | Coyne Terrance P. EVP & CFO | $0 | 29,502 | +1% | No | |
|
|
||||||
| Aug. 7, 2026 filed Aug. 5, 2026 | Hite Christopher EVP & Chairman, Partnering | $0 | 11,002 | +2% | No | |
|
|
||||||
Showing the 5 most recent of 9 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free